Cargando…

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus

OBJECTIVE: To describe the clinical features of late-onset (≥50 years) neuromyelitis optica spectrum disorder (LO-NMOSD), to compare the outcome with that of early-onset (EO-NMOSD), and to identify predictors of disability. METHODS: A retrospective, multicenter study of 238 patients with NMOSD ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sepulveda, Maria, Delgado-García, Guillermo, Blanco, Yolanda, Sola-Valls, Nuria, Martinez-Lapiscina, Elena H., Armangué, Thaís, Montejo, Carmen, Pulido-Valdeolivas, Irene, Martinez-Hernandez, Eugenia, Ariño, Helena, Escudero, Domingo, Ruiz-García, Raquel, Llufriu, Sara, Dalmau, Josep, Graus, Francesc, Saiz, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745725/ https://www.ncbi.nlm.nih.gov/pubmed/31471461 http://dx.doi.org/10.1212/NXI.0000000000000607

Ejemplares similares

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
por: Sepúlveda, Maria, et al.
Publicado: (2016)

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
por: Zubizarreta, Irati, et al.
Publicado: (2019)

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine
por: Sola-Valls, Núria, et al.
Publicado: (2018)

Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
por: Sepúlveda, Maria, et al.
Publicado: (2021)

Impact of Cognitive Reserve and Structural Connectivity on Cognitive Performance in Multiple Sclerosis
por: Lopez-Soley, Elisabet, et al.
Publicado: (2020)

Ependyma: a new target for autoantibodies in neuromyelitis optica?
por: Bigotte, Maxime, et al.
Publicado: (2022)

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis
por: Solana, Elisabeth, et al.
Publicado: (2018)

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis
por: Sola-Valls, Nuria, et al.
Publicado: (2019)

Predictors of vision impairment in Multiple Sclerosis
por: Sanchez-Dalmau, Bernardo, et al.
Publicado: (2018)

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients
por: Roura, Eloy, et al.
Publicado: (2021)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center
por: Ariño, Helena, et al.
Publicado: (2023)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients★
por: Li, Miao, et al.
Publicado: (2013)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2017)

Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
por: Solana, Elisabeth, et al.
Publicado: (2021)

Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-D-aspartate receptor antibodies are part of the problem
por: Höftberger, Romana, et al.
Publicado: (2013)

Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis
por: Guasp, Mar, et al.
Publicado: (2020)

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria
por: Kim, Yeseul, et al.
Publicado: (2017)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
por: Papp, Viktoria, et al.
Publicado: (2021)

Bilateral Internuclear Ophthalmoplegia in a Patient with Devic's Neuromyelitis Optica
por: Garcia-Martin, E., et al.
Publicado: (2010)

In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis
por: Alba-Arbalat, Salut, et al.
Publicado: (2021)

Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
por: Lopez-Soley, Elisabet, et al.
Publicado: (2022)

The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested
por: Ruiz-García, Raquel, et al.
Publicado: (2020)

Neuromyelitis Optica in Child: Diagnostic and Therapeutic Challenges
por: Dembinski, Karolina, et al.
Publicado: (2013)

Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity
por: Pisani, Francesco, et al.
Publicado: (2013)

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
por: Marignier, R., et al.
Publicado: (2016)

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years
por: Pulido-Valdeolivas, Irene, et al.
Publicado: (2020)

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
por: Lopez-Soley, Elisabet, et al.
Publicado: (2021)

Vanishing spinal cord after varicella-zoster virus myelitis
por: Sepúlveda, María, et al.
Publicado: (2017)

Retinal Optical Coherence Tomography in Neuromyelitis Optica
por: Oertel, Frederike Cosima, et al.
Publicado: (2021)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder
por: Meca-Lallana, Jose E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_305rqj298d69a99v2bga7hnd8q